相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patients
Andrea Rigarnonti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles
Moira Graves et al.
FRONTIERS IN MEDICINE (2019)
Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer
Yuki Kataoka et al.
ANTICANCER RESEARCH (2018)
Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population
Y. Fujisawa et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
Aya Nakaya et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
Tatsunori Kiriu et al.
PLOS ONE (2018)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Mariaelena Capone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies
Aixa E. Soyano et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer
Isamu Watanabe et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab (vol 27, pg 732, 2016)
P. F. Ferrucci et al.
ANNALS OF ONCOLOGY (2018)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Stephen J. Bagley et al.
LUNG CANCER (2017)
Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
Yuko Oya et al.
ONCOTARGET (2017)
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
Yoshihiko Taniguchi et al.
ANTICANCER RESEARCH (2017)
Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer
Satoru Okada et al.
ANNALS OF THORACIC SURGERY (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Cancer immunotherapies targeting the PD-1 signaling pathway
Yoshiko Iwai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
J. Zaragoza et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Prognostic Significance of Inflammatory and Nutritional Parameters in Patients with Esophageal Cancer
Tatsuya Miyazaki et al.
ANTICANCER RESEARCH (2016)
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S. Diem et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
Yong Joon Lee et al.
ANNALS OF COLOPROCTOLOGY (2016)
Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer
Fahriye Tugba Kos et al.
Asian Pacific Journal of Cancer Prevention (2015)
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
P. F. Ferrucci et al.
BRITISH JOURNAL OF CANCER (2015)
Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection
Ryuma Tokunaga et al.
DISEASES OF THE COLON & RECTUM (2015)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer
Wan Kyu Eo et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients
Shaodong Hong et al.
TUMOR BIOLOGY (2015)
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Sander Kelderman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Inflammation as a tumor promoter in cancer induction
M Philip et al.
SEMINARS IN CANCER BIOLOGY (2004)
分享论文
